Skip to content

OptimizeMe Nutrition

on a Weight Loss Drug That… Works?

The Consistency Project
The Consistency Project
on a Weight Loss Drug That... Works?

The soundbyte summary: Semaglutide (sold as Wegovy) acts on appetite centers in the brain and in the gut, producing feelings of satiety and reducing cravings. In a clinical trial, one-third of participants experienced 20% weight loss, which is unprecedented for a weight loss drug.

Topics include:

  • How our metabolism regulates energy balance;
  • How the body fat defends against fat loss;
  • How the drug semaglutide (sold as Wegovy or Ozempic) works and how effective it has been;
  • Drawbacks to taking the drug;
  • Who should consider taking it versus making basic diet & lifestyle changes?

Referenced Articles

Guyenet & Schwartz, 2012. Rats are attracted to high-fat diet
Hall & Kahan, 2018. Maintenance of lost weight and long-term management of obesity
Wilding et al., 2021. Semaglutide clinical trial where >70% of participants experienced 10% weight loss
Rubino et al., 2021. Semaglutide clinical trial where participants regained weight after they went off the drug.

Referenced Podcasts

On Five Takeaways from a Book Worth Reading (Burn)



OptimizeMe Nutrition Products

#800gChallenge® Ebook
Lazy Macros® Ebook
Affiliate Coach Program

>>And join the email list for bonus content.